Seelos Therapeutics, Inc.
SEELDelisted Apr 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001017491
Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Seelos Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 86
- −2 vs. Q1 2022
- Shares held
- 31.3M
- −8.03M (−20.4%) vs. Q1 2022
- Total value
- $21.3M
- −$11.6M (−35.2%) vs. Q1 2022
- New holders
- 20
- 19 more added
- Sold out
- 22
- 29 more reduced
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SEEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 3 | $4.77K |
| Q3 2024 | 15 | $145.2K |
| Q2 2024 | 23 | $129.4K |
| Q1 2024 | 36 | $1.55M |
| Q4 2023 | 39 | $2.48M |
| Q3 2023 | 82 | $7.01M |
| Q2 2023 | 83 | $27.1M |
| Q1 2023 | 80 | $15.1M |
| Q4 2022 | 80 | $15.6M |
| Q3 2022 | 85 | $28.0M |
| Q2 2022 | 86 | $21.3M |
| Q1 2022 | 92 | $33.0M |
| Q4 2021 | 97 | $65.9M |
| Q3 2021 | 110 | $98.2M |
| Q2 2021 | 105 | $107.8M |
| Q1 2021 | 73 | $124.8M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Seelos Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Principal Financial Group Inc | 0 | $0 | 0.00% | −29,894−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −24,378−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −22,116−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −18,419−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −15,948−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −15,994−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −5,944−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −254−100.0% | Sold out |
| WealthPLAN Partners, LLC | – | – | – | – | Not filed |
| WealthPlan Investment Management, LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |
| Nauset Wealth Management. LLC | – | – | – | – | Not filed |